REQUEST A DEMO
Total
USD $0.00
Search more companies

Ips Clinica Roque Armando Lopez Alvarez E.U. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Ips Clinica Roque Armando Lopez Alvarez E.U. Profile Updated: January 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Ips Clinica Roque Armando Lopez Alvarez E.U. is based in Colombia, with the head office in Supia. The company operates in the Ambulatory Health Care Services industry. It was established on February 04, 2008. The total number of employees is currently 149 (2025). The company’s latest financial report indicates a net sales revenue increase of 13.31% in 2025. During that time, Ips Clinica Roque Armando Lopez Alvarez E.U.’s total assets grew by 27.56%. The net profit margin of Ips Clinica Roque Armando Lopez Alvarez E.U. increased by 2.27% in 2025.

Headquarters
Cra 7 32-15
Supia; Caldas;

Contact Details: Purchase the Ips Clinica Roque Armando Lopez Alvarez E.U. report to view the information.

Basic Information
Total Employees:
Purchase the Ips Clinica Roque Armando Lopez Alvarez E.U. report to view the information.
Registered Capital:
Purchase the Ips Clinica Roque Armando Lopez Alvarez E.U. report to view the information.
Financial Auditors:
Purchase the Ips Clinica Roque Armando Lopez Alvarez E.U. report to view the information.
Incorporation Date:
February 04, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Ips Clinica Roque Armando Lopez Alvarez E.U. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
13.31%
Total Operating Revenue
13.31%
Operating Profit
45.28%
EBITDA
45.28%
Net Profit/Loss for the Period
45.28%
Total Assets
27.56%
Total Equity
30.38%
Operating Profit Margin
2.27%
Net Profit Margin
2.27%
Return on Equity (ROE)
0.85%
Quick Ratio
5.23%
Cash Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?